AI assistant
Sending…
Sonoma Pharmaceuticals, Inc. — Director's Dealing 2007
Jun 19, 2007
35312_dirs_2007-06-19_28fe041a-58c1-48c1-8a07-f7fd88b75c04.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Oculus Innovative Sciences, Inc. (OCLS)
CIK: 0001367083
Period of Report: 2007-06-15
Reporting Person: French Gregory M (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-06-15 | Stock Option (right to buy) | $7.27 | A | 10000 | Acquired | 2012-06-15 | Common Stock (10000) | Direct |
Footnotes
F1: The option vests as to 1/12th on the 15th of each successive month after grant.
More from Sonoma Pharmaceuticals, Inc.
Capital/Financing Update
2026
Apr 30
Capital/Financing Update
2026
Apr 27
Capital/Financing Update
2026
Apr 17
Regulatory Filings
2026
Apr 9
Interim / Quarterly Report
2026
Feb 10
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 28
Investor Presentation
2026
Jan 12
Director's Dealing
2026
Jan 2
Director's Dealing
2026
Jan 2